Evidence-gap & search-audit record

Question: of the app pages that render with fewer than two poolable trials (k<2), how many are genuine evidence gaps (≤1 RCT exists in the world) versus our own registry-only search failure (RCTs exist in PubMed / Europe PMC that the registry snapshot missed)?

Method: three-layer existence search — ClinicalTrials.gov/AACT (already run) → PubMed (NCBI) → Europe PMC open-access. Run over all 260 k<2 apps (35 k=0, 225 k=1). A datum counts as available if RCTs are found in ANY layer.

Result: 260 → 259 rescued, 1 genuine evidence gap

259 of 260 apps (99.6%) have ≥2 RCTs findable in PubMed / Europe PMC. Their low k was our search failure, not an absence of evidence — they are KEPT. (Adding the found trials is the pending extraction step; the pages honestly show their current k in the meantime.)

Genuine evidence gap (delisted from browse, file kept with a NOT-POOLABLE notice)

Olutasidenib in IDH1-mutated relapsed/refractory AML — 0 randomized controlled trials in PubMed (NCBI esearch RCT[pt]=0), Europe PMC (PUB_TYPE:RCT=0), and confirmed by an independent model (agy/Gemini: "COUNT=0, None exist"). Olutasidenib (Rezlidhia) was FDA-approved on a single-arm study (2102-HEM-101). This is a real evidence gap: there is no randomized evidence for this drug in this indication. The app is removed from the gallery/audit listings; its direct URL still resolves and shows a "NOT POOLABLE" notice. Files: OLUTASIDENIB_AML_REVIEW_FULL_REVIEW.html, OLUTASIDENIB_AML_REVIEW.html.

This record is deliberately public: a delisted app that vanishes silently is its own dishonesty. "No randomized evidence exists for this question" is itself a finding a researcher needs.

Rescued apps (259) — RCTs exist, kept

app	drug	condition	RCTs found (EuropePMC)
ABALOPARATIDE_OSTEO_AUTO_FULL_REVIEW.html	Abaloparatide	osteoporosis	52
ABALOPARATIDE_OSTEO_AUTO_REVIEW.html	Abaloparatide	osteoporosis	52
ACORAMIDIS_ATTR_CM_REVIEW.html	Acoramidis		12
ADC_HER2_ADJUVANT_REVIEW.html	ADC NMA	HER2+ Early Breast Cancer Adjuvant	0
AFICAMTEN_HCM_REVIEW.html	Aficamten		23
AGALSIDASE_FABRY_AUTO_FULL_REVIEW.html	Agalsidase alfa/beta	Fabry	12
AGALSIDASE_FABRY_AUTO_REVIEW.html	Agalsidase alfa/beta	Fabry	12
ALDO_SYNTHASE_REVIEW.html	Aldosterone Synthase Inhibitors	Resistant Hypertension	22
ALPELISIB_BREAST_AUTO_FULL_REVIEW.html	Alpelisib	PIK3CA-mutant breast	22
ALPELISIB_BREAST_AUTO_REVIEW.html	Alpelisib	PIK3CA-mutant breast	22
APREMILAST_BEHCET_AUTO_FULL_REVIEW.html	Apremilast	BehÃ§et oral ulcers	0
APREMILAST_BEHCET_AUTO_REVIEW.html	Apremilast	BehÃ§et oral ulcers	0
ARIPIPRAZOLE_SCHIZO_AUTO_FULL_REVIEW.html	Aripiprazole	schizophrenia	621
ARIPIPRAZOLE_SCHIZO_AUTO_REVIEW.html	Aripiprazole	schizophrenia	621
ASFOTASE_HPP_AUTO_FULL_REVIEW.html	Asfotase alfa	hypophosphatasia	5
AVACOPAN_ANCA_REVIEW_FULL_REVIEW.html	Avacopan	ANCA-associated vasculitis	10
AVALGLUCOSIDASE_AUTO_FULL_REVIEW.html	Avalglucosidase alfa Pompe		7
AVALGLUCOSIDASE_AUTO_REVIEW.html	Avalglucosidase alfa Pompe		7
AVALGLUCOSIDASE_POMPE_AUTO_FULL_REVIEW.html	Avalglucosidase alfa	Pompe	7
AVALGLUCOSIDASE_POMPE_AUTO_REVIEW.html	Avalglucosidase alfa	Pompe	7
AVELUMAB_OVARIAN_CANCER_AUTO_FULL_REVIEW.html	Avelumab	Ovarian Cancer	14
AVELUMAB_OVARIAN_CANCER_AUTO_REVIEW.html	Avelumab	Ovarian Cancer	14
BAMLANIVIMAB_COVID_AUTO_FULL_REVIEW.html	Bamlanivimab	COVID-19	67
BAMLANIVIMAB_COVID_AUTO_REVIEW.html	Bamlanivimab	COVID-19	67
BAMLANIVIMAB_OUTP_AUTO_FULL_REVIEW.html	Bamlanivimab outpatient COVID		25
BAMLANIVIMAB_OUTP_AUTO_REVIEW.html	Bamlanivimab outpatient COVID		25
BARDOXOLONE_CKD_AUTO_FULL_REVIEW.html	Bardoxolone	Alport/CKD	6
BARDOXOLONE_CKD_AUTO_REVIEW.html	Bardoxolone	Alport/CKD	6
BENRALIZUMAB_CRSWNP_AUTO_FULL_REVIEW.html	Benralizumab	CRSwNP	8
BENRALIZUMAB_CRSWNP_AUTO_REVIEW.html	Benralizumab	CRSwNP	8
BUDESONIDE_ASTHMA_AUTO_FULL_REVIEW.html	Budesonide	asthma	1482
BUDESONIDE_ASTHMA_AUTO_REVIEW.html	Budesonide	asthma	1482
CABAZITAXEL_PROSTATE_AUTO_FULL_REVIEW.html	Cabazitaxel	mCRPC	102
CABAZITAXEL_PROSTATE_AUTO_REVIEW.html	Cabazitaxel	mCRPC	102
CAPIVASERTIB_BC_REVIEW.html	Capivasertib + Fulvestrant	HR+/HER2- Advanced Breast Cancer	17
CASIRIVIMAB_COVID_AUTO_FULL_REVIEW.html	Casirivimab/imdevimab	COVID-19	91
CASIRIVIMAB_COVID_AUTO_REVIEW.html	Casirivimab/imdevimab	COVID-19	91
CASPOFUNGIN_FUNGAL_AUTO_FULL_REVIEW.html	Caspofungin	candidiasis	56
CASPOFUNGIN_FUNGAL_AUTO_REVIEW.html	Caspofungin	candidiasis	56
CINRYZE_HAE_AUTO_FULL_REVIEW.html	C1-INH replacement		10
CINRYZE_HAE_AUTO_REVIEW.html	C1-INH replacement		10
DAPAGLIFLOZIN_T2D_CV_AUTO_FULL_REVIEW.html	Dapagliflozin CVOT	T2D	4
DAPAGLIFLOZIN_T2D_CV_AUTO_REVIEW.html	Dapagliflozin CVOT	T2D	4
DAPRODUSTAT_ANAEMIA_AUTO_FULL_REVIEW.html	Daprodustat	Anaemia	5
DAPRODUSTAT_ANAEMIA_AUTO_REVIEW.html	Daprodustat	Anaemia	5
DASABUVIR_CHRONIC_HEPATITIS_AUTO_FULL_REVIEW.html	Dasabuvir	Chronic Hepatitis C Infection	35
DASABUVIR_CHRONIC_HEPATITIS_AUTO_REVIEW.html	Dasabuvir	Chronic Hepatitis C Infection	35
DEFEROXAMINE_IRON_AUTO_FULL_REVIEW.html	Deferoxamine	iron overload	74
DEFEROXAMINE_IRON_AUTO_REVIEW.html	Deferoxamine	iron overload	74
DELANDISTROGENE_DMD_REVIEW.html	Delandistrogene Moxeparvovec Gene Therapy	Duchenne Muscular Dystrophy	3
DENOSUMAB_BONE_MET_AUTO_FULL_REVIEW.html	Denosumab	bone metastases	116
DENOSUMAB_BONE_MET_AUTO_REVIEW.html	Denosumab	bone metastases	116
DENOSUMAB_OSTEO_AUTO_FULL_REVIEW.html	Denosumab	osteoporosis	395
DENOSUMAB_OSTEO_AUTO_REVIEW.html	Denosumab	osteoporosis	395
DEXAMETHASONE_DME_AUTO_FULL_REVIEW.html	Dexamethasone implant	DME	48
DEXAMETHASONE_DME_AUTO_REVIEW.html	Dexamethasone implant	DME	48
DEXAMETHASONE_IMPLANT_AUTO_FULL_REVIEW.html	Dexamethasone intravitreal implant		129
DEXAMETHASONE_IMPLANT_AUTO_REVIEW.html	Dexamethasone intravitreal implant		129
DEXAMETHASONE_INTRAVITREAL_AUTO_FULL_REVIEW.html	Dexamethasone implant	DME/uveitis	8
DEXAMETHASONE_INTRAVITREAL_AUTO_REVIEW.html	Dexamethasone implant	DME/uveitis	8
DONANEMAB_AD_SOLO_REVIEW.html	Donanemab		68
DURVALUMAB_ENDOMETRIAL_AUTO_FULL_REVIEW.html	Durvalumab	endometrial	18
DURVALUMAB_ENDOMETRIAL_AUTO_REVIEW.html	Durvalumab	endometrial	18
ECULIZUMAB_GMG_AUTO_FULL_REVIEW.html	Eculizumab	gMG	19
ECULIZUMAB_GMG_AUTO_REVIEW.html	Eculizumab	gMG	19
ECULIZUMAB_MYASTHENIA_AUTO_FULL_REVIEW.html	Eculizumab	MG/NMOSD	17
ECULIZUMAB_MYASTHENIA_AUTO_REVIEW.html	Eculizumab	MG/NMOSD	17
ELACESTRANT_BC_REVIEW.html	Elacestrant	ESR1-Mutated HR+/HER2- Advanced Breast Cancer	12
ELAGOLIX_ENDOMETRIOSIS_AUTO_FULL_REVIEW.html	Elagolix	endometriosis	29
ELAGOLIX_ENDOMETRIOSIS_AUTO_REVIEW.html	Elagolix	endometriosis	29
ELAGOLIX_ENDO_AUTO_FULL_REVIEW.html	Elagolix	endometriosis	29
ELAGOLIX_ENDO_AUTO_REVIEW.html	Elagolix	endometriosis	29
EMTRICITABINE_HIV_AUTO_FULL_REVIEW.html	Emtricitabine + TDF/TAF backbone HIV		25
EMTRICITABINE_HIV_AUTO_REVIEW.html	Emtricitabine + TDF/TAF backbone HIV		25
EPOETIN_CANCER_AUTO_FULL_REVIEW.html	Epoetin	chemo-induced anaemia	2
EPOETIN_CANCER_AUTO_REVIEW.html	Epoetin	chemo-induced anaemia	2
ERDAFITINIB_BLADDER_AUTO_FULL_REVIEW.html	Erdafitinib	FGFR+ urothelial	12
ERDAFITINIB_BLADDER_AUTO_REVIEW.html	Erdafitinib	FGFR+ urothelial	12
ETEPLIRSEN_DMD_AUTO_FULL_REVIEW.html	Eteplirsen	DMD	14
ETEPLIRSEN_DMD_AUTO_REVIEW.html	Eteplirsen	DMD	14
ETESEVIMAB_COVID_AUTO_FULL_REVIEW.html	Etesevimab + bamlanivimab COVID		41
ETESEVIMAB_COVID_AUTO_REVIEW.html	Etesevimab + bamlanivimab COVID		41
ETROLIZUMAB_CD_AUTO_FULL_REVIEW.html	Etrolizumab	Crohn	7
ETROLIZUMAB_CD_AUTO_REVIEW.html	Etrolizumab	Crohn	7
EVEROLIMUS_BREAST_AUTO_FULL_REVIEW.html	Everolimus	HR+ breast	146
EVEROLIMUS_BREAST_AUTO_REVIEW.html	Everolimus	HR+ breast	146
EVINACUMAB_HOFH_AUTO_FULL_REVIEW.html	Evinacumab	HoFH	6
EVINACUMAB_HOFH_AUTO_REVIEW.html	Evinacumab	HoFH	6
EVOLOCUMAB_ASCVD_AUTO_2_FULL_REVIEW.html	Evolocumab	ASCVD secondary prevention	18
EZETIMIBE_LIPID_AUTO_FULL_REVIEW.html	Ezetimibe	hyperlipidemia	133
GIVINOSTAT_DMD_AUTO_FULL_REVIEW.html	Givinostat	DMD	2
GIVINOSTAT_DMD_AUTO_REVIEW.html	Givinostat	DMD	2
ICATIBANT_HAE_AUTO_FULL_REVIEW.html	Icatibant	acute HAE	11
ICATIBANT_HAE_AUTO_REVIEW.html	Icatibant	acute HAE	11
IDURSULFASE_MPS2_AUTO_FULL_REVIEW.html	Idursulfase	MPS II	13
IDURSULFASE_MPS2_AUTO_REVIEW.html	Idursulfase	MPS II	13
INAVOLISIB_BC_REVIEW.html	Inavolisib + Palbociclib + Fulvestrant	PIK3CA-Mutated HR+/HER2- Advanced BC	0
INCLISIRAN_HOFH_AUTO_FULL_REVIEW.html	Inclisiran	HoFH	3
INCLISIRAN_HOFH_AUTO_REVIEW.html	Inclisiran	HoFH	3
INDACATEROL_COPD_AUTO_FULL_REVIEW.html	Indacaterol	COPD	188
INDACATEROL_COPD_AUTO_REVIEW.html	Indacaterol	COPD	188
INOTERSEN_ATTR_PN_AUTO_FULL_REVIEW.html	Inotersen	ATTR polyneuropathy	10
INOTERSEN_ATTR_PN_AUTO_REVIEW.html	Inotersen	ATTR polyneuropathy	10
INOTERSEN_FAP_AUTO_FULL_REVIEW.html	Inotersen	hereditary ATTR-PN	6
INOTERSEN_FAP_AUTO_REVIEW.html	Inotersen	hereditary ATTR-PN	6
INOTERSEN_HATTR_AUTO_FULL_REVIEW.html	Inotersen	hATTR-PN	7
INOTERSEN_HATTR_AUTO_REVIEW.html	Inotersen	hATTR-PN	7
IPTACOPAN_IGAN_REVIEW.html	Iptacopan		15
ISONIAZID_LTBI_AUTO_FULL_REVIEW.html	Isoniazid	LTBI	77
ISONIAZID_LTBI_AUTO_REVIEW.html	Isoniazid	LTBI	77
LAZERTINIB_LUNG_AUTO_FULL_REVIEW.html	Lazertinib + amivantamab	EGFR NSCLC	17
LAZERTINIB_LUNG_AUTO_REVIEW.html	Lazertinib + amivantamab	EGFR NSCLC	17
LEDIPASVIR_HCV_AUTO_FULL_REVIEW.html	Ledipasvir/sofosbuvir	HCV	88
LEDIPASVIR_HCV_AUTO_REVIEW.html	Ledipasvir/sofosbuvir	HCV	88
LISINOPRIL_HTN_AUTO_FULL_REVIEW.html	Lisinopril	HTN	23
LISINOPRIL_HTN_AUTO_REVIEW.html	Lisinopril	HTN	23
LUMASIRAN_PH1_AUTO_FULL_REVIEW.html	Lumasiran	primary hyperoxaluria	4
LUMASIRAN_PH1_AUTO_REVIEW.html	Lumasiran	primary hyperoxaluria	4
MARALIXIBAT_PFIC_REVIEW_FULL_REVIEW.html	Maralixibat	PFIC	4
MARIBAVIR_CMV_AUTO_FULL_REVIEW.html	Maribavir	refractory CMV	16
MARIBAVIR_CMV_AUTO_REVIEW.html	Maribavir	refractory CMV	16
MAVACAMTEN_OHCM_AUTO_FULL_REVIEW.html	Mavacamten	obstructive HCM	31
MAVACAMTEN_OHCM_AUTO_REVIEW.html	Mavacamten	obstructive HCM	31
MEN_ACWY_AUTO_FULL_REVIEW.html	Quadrivalent meningococcal MenACWY		85
MEN_ACWY_AUTO_REVIEW.html	Quadrivalent meningococcal MenACWY		85
METFORMIN_T2D_AUTO_FULL_REVIEW.html	Metformin	T2D	812
METFORMIN_T2D_AUTO_REVIEW.html	Metformin	T2D	812
METHADONE_OUD_AUTO_FULL_REVIEW.html	Methadone maintenance OUD		153
METHADONE_OUD_AUTO_REVIEW.html	Methadone maintenance OUD		153
MIRVETUXIMAB_OVARIAN_REVIEW_FULL_REVIEW.html	Mirvetuximab soravtansine FRÎ±+ ovarian		0
MITAPIVAT_PYRUVATE_AUTO_FULL_REVIEW.html	Mitapivat	PK deficiency	5
MITAPIVAT_PYRUVATE_AUTO_REVIEW.html	Mitapivat	PK deficiency	5
MITAPIVAT_THALASSEMIA_REVIEW.html	Mitapivat		8
NEMOLIZUMAB_PRURIGO_REVIEW_FULL_REVIEW.html	Nemolizumab	prurigo nodularis	11
NEPA_CINV_AUTO_FULL_REVIEW.html	NEPA		50
NEPA_CINV_AUTO_REVIEW.html	NEPA		50
NETUPITANT_CINV_AUTO_FULL_REVIEW.html	Netupitant/palonosetron	CINV	42
NETUPITANT_CINV_AUTO_REVIEW.html	Netupitant/palonosetron	CINV	42
OBICETRAPIB_LIPID_AUTO_FULL_REVIEW.html	Obicetrapib		9
OBINUTUZUMAB_LN_AUTO_FULL_REVIEW.html	Obinutuzumab	lupus nephritis	6
OBINUTUZUMAB_LN_AUTO_REVIEW.html	Obinutuzumab	lupus nephritis	6
OLAPARIB_OVARIAN2_AUTO_FULL_REVIEW.html	Olaparib	ovarian	151
OLAPARIB_OVARIAN2_AUTO_REVIEW.html	Olaparib	ovarian	151
OLAPARIB_OVARIAN_AUTO_FULL_REVIEW.html	Olaparib	ovarian cancer	151
OLAPARIB_OVARIAN_AUTO_REVIEW.html	Olaparib	ovarian cancer	151
OMALIZUMAB_FOOD_ALLERGY_AUTO_FULL_REVIEW.html	Omalizumab	food allergy	67
OMALIZUMAB_FOOD_ALLERGY_AUTO_REVIEW.html	Omalizumab	food allergy	67
OMBITASVIR_CHRONIC_HEPATITIS_AUTO_FULL_REVIEW.html	Ombitasvir	Chronic Hepatitis C Infection	47
OMBITASVIR_CHRONIC_HEPATITIS_AUTO_REVIEW.html	Ombitasvir	Chronic Hepatitis C Infection	47
OMECAMTIV_HEARTFAIL_AUTO_FULL_REVIEW.html	Omecamtiv mecarbil	HFrEF	18
OMECAMTIV_HEARTFAIL_AUTO_REVIEW.html	Omecamtiv mecarbil	HFrEF	18
OMECAMTIV_HFREF_AUTO_FULL_REVIEW.html	Omecamtiv mecarbil	HFrEF	18
OMECAMTIV_HFREF_AUTO_REVIEW.html	Omecamtiv mecarbil	HFrEF	18
OMECAMTIV_HF_AUTO_FULL_REVIEW.html	Omecamtiv mecarbil	HFrEF	18
OMECAMTIV_HF_AUTO_REVIEW.html	Omecamtiv mecarbil	HFrEF	18
OSIMERTINIB_ADJUVANT_AUTO_FULL_REVIEW.html	Osimertinib	in EGFR NSCLC	149
OSIMERTINIB_ADJUVANT_AUTO_REVIEW.html	Osimertinib	in EGFR NSCLC	149
OSIMERTINIB_LUNG_AUTO_FULL_REVIEW.html	Osimertinib	EGFR-mutant NSCLC	65
OSIMERTINIB_LUNG_AUTO_REVIEW.html	Osimertinib	EGFR-mutant NSCLC	65
PALIFERMIN_MUCOSITIS_AUTO_FULL_REVIEW.html	Palifermin	mucositis	47
PALIFERMIN_MUCOSITIS_AUTO_REVIEW.html	Palifermin	mucositis	47
PARITAPREVIR_CHRONIC_HEPATITIS_AUTO_FULL_REVIEW.html	Paritaprevir	Chronic Hepatitis C Infection	48
PARITAPREVIR_CHRONIC_HEPATITIS_AUTO_REVIEW.html	Paritaprevir	Chronic Hepatitis C Infection	48
PATISIRAN_ATTR_PN_AUTO_FULL_REVIEW.html	Patisiran	ATTR polyneuropathy	17
PATISIRAN_ATTR_PN_AUTO_REVIEW.html	Patisiran	ATTR polyneuropathy	17
PATISIRAN_HATTR_AUTO_FULL_REVIEW.html	Patisiran	hATTR-PN	6
PATISIRAN_HATTR_AUTO_REVIEW.html	Patisiran	hATTR-PN	6
PEGCETACOPLAN_PNH_AUTO_FULL_REVIEW.html	Pegcetacoplan	PNH	16
PEGCETACOPLAN_PNH_AUTO_REVIEW.html	Pegcetacoplan	PNH	16
PEMBROLIZUMAB_KIDNEY_ADJ_AUTO_2_FULL_REVIEW.html	Pembrolizumab	RCC	174
PEMBROLIZUMAB_KIDNEY_ADJ_AUTO_FULL_REVIEW.html	Pembrolizumab	RCC	174
PEMBROLIZUMAB_KIDNEY_ADJ_AUTO_REVIEW.html	Pembrolizumab	RCC	174
PEMBROLIZUMAB_MELANOMA_ADJ_AUTO_FULL_REVIEW.html	Pembrolizumab	melanoma	694
PEMBROLIZUMAB_MELANOMA_ADJ_AUTO_REVIEW.html	Pembrolizumab	melanoma	694
PEMBROLIZUMAB_MELANOMA_AUTO_FULL_REVIEW.html	Pembrolizumab	melanoma	694
PEMBROLIZUMAB_MELANOMA_AUTO_REVIEW.html	Pembrolizumab	melanoma	694
PEMBROLIZUMAB_MELANOMA_NEO_AUTO_FULL_REVIEW.html	Pembrolizumab neoadjuvant melanoma		167
PEMBROLIZUMAB_MELANOMA_NEO_AUTO_REVIEW.html	Pembrolizumab neoadjuvant melanoma		167
PEMBROLIZUMAB_RCC_AUTO_FULL_REVIEW.html	Pembrolizumab + axitinib RCC		67
PEMBROLIZUMAB_RCC_AUTO_REVIEW.html	Pembrolizumab + axitinib RCC		67
PEMBROLIZUMAB_RENAL_AUTO_FULL_REVIEW.html	Pembrolizumab	RCC	174
PEMBROLIZUMAB_RENAL_AUTO_REVIEW.html	Pembrolizumab	RCC	174
PEMIGATINIB_BTC_AUTO_FULL_REVIEW.html	Pemigatinib	CCA	4
PEMIGATINIB_BTC_AUTO_REVIEW.html	Pemigatinib	CCA	4
PEMIGATINIB_CHOLANGIO_AUTO_FULL_REVIEW.html	Pemigatinib	cholangiocarcinoma	7
PEMIGATINIB_CHOLANGIO_AUTO_REVIEW.html	Pemigatinib	cholangiocarcinoma	7
PIBRENTASVIR_HEPATITIS_C_AUTO_FULL_REVIEW.html	Pibrentasvir	Hepatitis C Virus	34
PIBRENTASVIR_HEPATITIS_C_AUTO_REVIEW.html	Pibrentasvir	Hepatitis C Virus	34
PIOGLITAZONE_T2D_AUTO_FULL_REVIEW.html	Pioglitazone	T2D	86
RAMUCIRUMAB_HCC_AUTO_FULL_REVIEW.html	Ramucirumab	HCC	29
RAMUCIRUMAB_HCC_AUTO_REVIEW.html	Ramucirumab	HCC	29
REMDESIVIR_COVID_AUTO_FULL_REVIEW.html	Remdesivir	COVID-19	542
REMDESIVIR_COVID_AUTO_REVIEW.html	Remdesivir	COVID-19	542
RESMETIROM_MASH_REVIEW.html	Resmetirom		35
ROMOSOZUMAB_OP_REVIEW.html	Romosozumab	Postmenopausal Osteoporosis	59
ROMOSOZUMAB_OSTEO_AUTO_FULL_REVIEW.html	Romosozumab	osteoporosis	68
ROMOSOZUMAB_OSTEO_AUTO_REVIEW.html	Romosozumab	osteoporosis	68
ROZANOLIXIZUMAB_MG_AUTO_FULL_REVIEW.html	Rozanolixizumab	gMG	9
ROZANOLIXIZUMAB_MG_AUTO_REVIEW.html	Rozanolixizumab	gMG	9
RUCAPARIB_PROSTATE2_AUTO_FULL_REVIEW.html	Rucaparib	BRCA+ mCRPC	6
RUCAPARIB_PROSTATE2_AUTO_REVIEW.html	Rucaparib	BRCA+ mCRPC	6
RUCAPARIB_PROSTATE_AUTO_FULL_REVIEW.html	Rucaparib	mCRPC	10
RUCAPARIB_PROSTATE_AUTO_REVIEW.html	Rucaparib	mCRPC	10
RUFINAMIDE_EPILEPSY_AUTO_FULL_REVIEW.html	Rufinamide	LGS	15
RUFINAMIDE_EPILEPSY_AUTO_REVIEW.html	Rufinamide	LGS	15
RUSFERTIDE_PV_REVIEW.html	Rusfertide		6
SACUBITRIL_HEARTFAIL_AUTO_FULL_REVIEW.html	Sacubitril/valsartan	HF	327
SACUBITRIL_HEARTFAIL_AUTO_REVIEW.html	Sacubitril/valsartan	HF	327
SACUBITRIL_VALSARTAN_HF_AUTO_FULL_REVIEW.html	Sacubitril/valsartan	HF	327
SACUBITRIL_VALSARTAN_HF_AUTO_REVIEW.html	Sacubitril/valsartan	HF	327
SELEXIPAG_PAH_AUTO_FULL_REVIEW.html	Selexipag	PAH	34
SELEXIPAG_PAH_AUTO_REVIEW.html	Selexipag	PAH	34
SELPERCATINIB_RET_REVIEW_FULL_REVIEW.html	Selpercatinib	RET+ NSCLC/MTC	1
SELUMETINIB_NF1_AUTO_FULL_REVIEW.html	Selumetinib	NF1 plexiform	4
SELUMETINIB_NF1_AUTO_REVIEW.html	Selumetinib	NF1 plexiform	4
SEMAGLUTIDE_NASH_AUTO_FULL_REVIEW.html	Semaglutide	NASH	53
SEMAGLUTIDE_NASH_AUTO_REVIEW.html	Semaglutide	NASH	53
SER109_CDI_AUTO_FULL_REVIEW.html	Fecal microbiota live		961
SER109_CDI_AUTO_REVIEW.html	Fecal microbiota live		961
SOTATERCEPT_PAH_REVIEW.html	Sotatercept	PAH	12
SPARSENTAN_IGAN_REVIEW.html	Sparsentan		9
SPESOLIMAB_GPP_AUTO_FULL_REVIEW.html	Spesolimab	generalized pustular psoriasis	11
SPESOLIMAB_GPP_AUTO_REVIEW.html	Spesolimab	generalized pustular psoriasis	11
SUMATRIPTAN_MIG_AUTO_FULL_REVIEW.html	Sumatriptan	acute migraine	455
SUMATRIPTAN_MIG_AUTO_REVIEW.html	Sumatriptan	acute migraine	455
SUTIMLIMAB_CAD_REVIEW_FULL_REVIEW.html	Sutimlimab	cold agglutinin disease	6
TALIGLUCERASE_GAUCHER_AUTO_FULL_REVIEW.html	Taliglucerase alfa	Gaucher	7
TECOVIRIMAT_MPOX_AUTO_FULL_REVIEW.html	Tecovirimat	mpox/smallpox	3
TECOVIRIMAT_MPOX_AUTO_REVIEW.html	Tecovirimat	mpox/smallpox	3
TENAPANOR_HYPERPHOS_AUTO_FULL_REVIEW.html	Tenapanor	hyperphosphatemia	16
TENAPANOR_HYPERPHOS_AUTO_REVIEW.html	Tenapanor	hyperphosphatemia	16
TEPLIZUMAB_T1D_REVIEW.html	Teplizumab	Delay of Stage 3 Type 1 Diabetes	21
TEPOTINIB_LUNG_AUTO_FULL_REVIEW.html	Tepotinib	MET-exon14 NSCLC	0
TEPOTINIB_LUNG_AUTO_REVIEW.html	Tepotinib	MET-exon14 NSCLC	0
TOFERSEN_ALS_AUTO_FULL_REVIEW.html	Tofersen	SOD1+ ALS	11
TOFERSEN_ALS_AUTO_REVIEW.html	Tofersen	SOD1+ ALS	11
TOFERSEN_SOD1_ALS_REVIEW_FULL_REVIEW.html	Tofersen	SOD1+ ALS	11
TRAMETINIB_MELANOMA_AUTO_FULL_REVIEW.html	Trametinib	BRAF+ melanoma	109
TRAMETINIB_MELANOMA_AUTO_REVIEW.html	Trametinib	BRAF+ melanoma	109
VAMOROLONE_DMD2_AUTO_FULL_REVIEW.html	Vamorolone	DMD	8
VAMOROLONE_DMD2_AUTO_REVIEW.html	Vamorolone	DMD	8
VAMOROLONE_DMD_REVIEW_FULL_REVIEW.html	Vamorolone	Duchenne	8
VANDETANIB_THYROID_AUTO_FULL_REVIEW.html	Vandetanib	MTC	24
VANDETANIB_THYROID_AUTO_REVIEW.html	Vandetanib	MTC	24
VARENICLINE_AUD_AUTO_FULL_REVIEW.html	Varenicline	AUD	88
VARENICLINE_AUD_AUTO_REVIEW.html	Varenicline	AUD	88
VENLAFAXINE_DEPRESSION_AUTO_FULL_REVIEW.html	Venlafaxine ER	MDD	32
VENLAFAXINE_DEPRESSION_AUTO_REVIEW.html	Venlafaxine ER	MDD	32
VOCLOSPORIN_LN_AUTO_FULL_REVIEW.html	Voclosporin	lupus nephritis	13
VOCLOSPORIN_LN_AUTO_REVIEW.html	Voclosporin	lupus nephritis	13
VOCLOSPORIN_LN_REVIEW.html	Voclosporin	lupus nephritis	13
VOCLOSPORIN_LUPUS_AUTO_FULL_REVIEW.html	Voclosporin	lupus nephritis	13
VOCLOSPORIN_LUPUS_AUTO_REVIEW.html	Voclosporin	lupus nephritis	13
VORASIDENIB_GLIOMA_REVIEW.html	Vorasidenib		3
VOXELOTOR_SCD_AUTO_2_FULL_REVIEW.html	Voxelotor	SCD	11
VOXELOTOR_SCD_AUTO_FULL_REVIEW.html	Voxelotor	SCD	11
VOXELOTOR_SCD_AUTO_REVIEW.html	Voxelotor	SCD	11
VUTRISIRAN_ATTR_REVIEW.html	Vutrisiran		22
ZURANOLONE_PPD_MDD_REVIEW_FULL_REVIEW.html	Zuranolone	MDD and PPD	4